Sign in

Atoosa Rabiee

@atoosarabiee.bsky.social
640 followers 312 following 108 posts

Transplant hepatologist Chief of Transplant|Director of Hepatology @DCVAMC @HopkinsMedicine@UMiamiHealth #liversky|#livercancer|#portalHT|#MEDed

PostsRepliesMedia
Reposted by Atoosa Rabiee
Dr. Jessica Davis @drjessicadavis.bsky.social · 10/11/2025
Had a great last day at #TLM2025 with inspiration and food for 🤔 👀 all 7 women @aasldnews.bsky.social presidents in one room (‼️) for the Women’s Luncheon 🔥🔥🔥discussion by @LaurenFeldMD and division chiefs on recruitment & retention of women hepatologists #liversky
171
Atoosa Rabiee @atoosarabiee.bsky.social · 10/11/2025
Next gen hepatology Session by communication and technology committee All brilliant speakers! Proud to have served as the chair of this committee @aasldnews.bsky.social #TLM25 #liversky @howardtleemd.bsky.social
030
Reposted by Atoosa Rabiee
Dr. Jessica Davis @drjessicadavis.bsky.social · 10/11/2025
📣 NEW 💫 class of @aasldnews.bsky.social Women’s Leadership Development program mentees & mentors It was lovely to celebrate you with an inspiring keynote talk from #AASLD25 President Dr. Grace Su Looking forward to the year ahead! #TLM2025 #liversky #gisky
131
Reposted by Atoosa Rabiee
Dr. Jessica Davis @drjessicadavis.bsky.social · 10/11/2025
➡️What happens when you increase salary transparency? ➡️What is on a chief’s 🧠when negotiating a new hire? ➡️How to ⚖️ accommodations & consistency? Find out in our 🔥🔥 #TLM2025 panel @aasldnews.bsky.social #liversky @ast-whcop.bsky.social @ast-licop.bsky.social
122
Atoosa Rabiee @atoosarabiee.bsky.social · 09/11/2025
Best practices of management of obesity in liver transplant FANTASTIC work by @drjessicadavis.bsky.social et al leading a controversy conference and consensus paper 👇🏼👇🏼👇🏼 Her beautiful graph won the cover photo 👌🏼 #liversky #TLM25 @aasldnews.bsky.social @ast-licop.bsky.social
062
Atoosa Rabiee @atoosarabiee.bsky.social · 09/11/2025
Great practical talk by @dougsimonetto.bsky.social #TLM25 #liversky
040
Atoosa Rabiee @atoosarabiee.bsky.social · 08/11/2025
Recompensation take home points ⏳off all diuretics and medications for HE 📌happens in 1 out of 3 patients depending etiology 🖋️multiple factors affect it 🔎 improves survival and LR mortality 📍Risk of HCC remains the same: don’t stop screening @anahitarabiee.bsky.social #liversky #TLM25
092
Reposted by Atoosa Rabiee
mattiasmandorfer.bsky.social @mattiasmandorfer.bsky.social · 08/11/2025
😀🇦🇹 multisociety (gastroenterology & hepatology, diabetology & obesity) consensus on MASLD (& MetALD!) 🤝Well-aligned with @easlnews.bsky.social CPGs 😟Reimbursement currently restricted to semaglutide for T2DM 🤔Reimbursement in your country? 🖇️: rdcu.be/eLAde #LiverSky @georg-semmler.bsky.social
044
Atoosa Rabiee @atoosarabiee.bsky.social · 08/11/2025
VA hepatitis C team winning the distinguished advocacy award. Truly well deserved 👏🏼 #liversky #TLM25
030
Atoosa Rabiee @atoosarabiee.bsky.social · 07/11/2025
Kicking off the meeting with some of my favorite people #TLM25 #liversky
020
Atoosa Rabiee @atoosarabiee.bsky.social · 27/10/2025
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update If you take care of patients with #HCC, do not miss this new update from BCLC #liversky @easlnews.bsky.social www.journal-of-hepatology.eu/article/S016....
043
Atoosa Rabiee @atoosarabiee.bsky.social · 27/10/2025
In anticipation of registration for @bavenocoop.bsky.social VIII Do not miss this new publication on refining Baveno VII criteria for CSPH individual-patient data meta-analysis #liversky pubmed.ncbi.nlm.nih.gov/41138818/ @easlnews.bsky.social
021
Atoosa Rabiee @atoosarabiee.bsky.social · 27/10/2025
Once bleeding is controlled with banding: Can duration of octreotide infusion be shortened? In this RCT, 1 v 5 days of Oct infusion post successful EVL was non inferior in prevention of bleeding and all-cause mortality #liversky @amcollegegastro.bsky.social pubmed.ncbi.nlm.nih.gov/41090987/
030
Atoosa Rabiee @atoosarabiee.bsky.social · 27/10/2025
📌A dual burden HCC risk is increased in MetALD compared to MASLD In a large cohort of VA patients, HCC risk MASLD>>MetALD>>ALD #liversky @easlnews.bsky.social www.sciencedirect.com/science/arti...
010
Atoosa Rabiee @atoosarabiee.bsky.social · 27/10/2025
Anecdotally, I have noticed this in my patients. Great to see a publication supporting this. Meta-Analysis of irAE using ICI in HCC irAEs correlated with superior PFS & OS specially derm, endocrine & low-grade events #liversky onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com
Meta‐Analysis: Immune‐Related Adverse Events Are Associated With Improved Effectiveness of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
irAEs, particularly dermatologic, endocrine and low-grade events, were associated with improved ICIs effectiveness in HCC. Early irAEs detection and corticosteroid management preserve survival benefi...
000
Atoosa Rabiee @atoosarabiee.bsky.social · 27/10/2025
📌 AGA clinical practice update on ascites and hyponatremia @amergastroassn.bsky.social #liversky www.gastrojournal.org/article/S001...
021
Reposted by Atoosa Rabiee
The Baveno Cooperation: an EASL Consortium @bavenocoop.bsky.social · 27/10/2025
⏳ Just 5 months left for #BavenoVIII! 🗓️ 27-28 March 2026 (👶 Pediatric Symposium: 29 March) 📍 Baveno, Italy 🌐 The event will take place in a hybrid formula — both in person and online. 🧠 Call for abstracts is now open! 🔗 More info at: baveno8.org 🧵
132
Reposted by Atoosa Rabiee
Dr. Jessica Davis @drjessicadavis.bsky.social · 26/10/2025
➡️What #livertransplant candidates should get #GLP1-RA? ➡️Best timing for #bariatricsurgery in transplant? ➡️Data for #GLP1-RA in #cirrhosis? 🚨check out our @amjtransplant.bsky.social best practices for #obesity & liver transplant 👇 doi.org/10.1016/j.aj... #liversky #GIsky #transplant
011
Atoosa Rabiee @atoosarabiee.bsky.social · 14/10/2025
Changes in trend and comparison of outcomes of TACE vs TARE as bridge therapy for patients with HCC on LT list #liversky @aasldnews.bsky.social
031
Atoosa Rabiee @atoosarabiee.bsky.social · 14/10/2025
Important study on use of ICI post-transplant Only one rejection! #liversky @aasldnews.bsky.social journals.lww.com/lt/abstract/...
021
Atoosa Rabiee @atoosarabiee.bsky.social · 14/10/2025
Ever wonder what happens to your liver after binge drinking? This study showed 📌increased hepatic fat fraction by 2.5-fold in healthy adults 📌increased liver stiffness 📌increased plasma triglycerides Good news: All normalized with 10 days of abstinence #liversky www.jhep-reports.eu/cms/10.1016/...
120
Atoosa Rabiee @atoosarabiee.bsky.social · 14/10/2025
Optimal sequencing post immunotherapy for HCC as first line A good overview #liversky @easlnews.bsky.social www.jhep-reports.eu/article/S258...
130
Atoosa Rabiee @atoosarabiee.bsky.social · 14/10/2025
Eye opening statistics re: HCC surveillance and how underutilized the guidelines are any HCC surveillance a little over 50% biannual surveillance 10% #liversky onlinelibrary.wiley.com/doi/epdf/10....
onlinelibrary.wiley.com
Meta‐Analysis: Utilisation of Hepatocellular Carcinoma Surveillance
Meta-analysis of 48 studies (1.28 M individuals) shows HCC surveillance remains underutilised despite guideline recommendations: only 54% of at-risk patients receive any ultrasound-based surveillance...
010
Atoosa Rabiee @atoosarabiee.bsky.social · 14/10/2025
RCT comparing TJ liver biopsy and HVPG vs EUS LB and PPG measurement Would LOVE to hear @juanc60.bsky.social and @virginiahdezgea.bsky.social editorial on this paper #liversky @amergastroassn.bsky.social www.cghjournal.org/article/S154...
cghjournal.org
EUS-GUIDED LIVER BIOPSY AND PORTAL PRESSURE MEASUREMENT COMPARED TO TRANSJUGULAR APPROACH: A RANDOMIZED CONTROLLED TRIAL
The transjugular (TJ) technique is recommended for the simultaneous evaluation of portal hypertension and hepatic fibrosis, with the hepatic venous pressure gradient (HVPG) and liver biopsy (LB), resp...
100
Atoosa Rabiee @atoosarabiee.bsky.social · 14/10/2025
Comprehensive review on evolution of immunotherapy for HCC #liversky #HCC @aasldnews.bsky.social journals.lww.com/hep/abstract...
000
Atoosa Rabiee @atoosarabiee.bsky.social · 14/10/2025
A great review on a not so common liver disease "Sarcoid in liver" #liversky @aasldnews.bsky.social journals.lww.com/hep/abstract...
000
Atoosa Rabiee @atoosarabiee.bsky.social · 14/10/2025
HES V2.0 biomarker panel (AFP, AFP-L3, and DCP, their gradient, if available), ALT, platelets, etiology showed higher sensitivity than GALAD at 12 months for HCC diagnosis #liversky @jhepatology.bsky.social www.journal-of-hepatology.eu/article/S016...
010
Atoosa Rabiee @atoosarabiee.bsky.social · 14/10/2025
If you are in the field of liver transplant, do not miss the 1st successful porcine liver xenotransplantation to a living recipient Postoperative xTMA -> significant challenge to long-term success #Liversky @jhepatology.bsky.social www.journal-of-hepatology.eu/article/S016...
010
Atoosa Rabiee @atoosarabiee.bsky.social · 14/10/2025
Beautiful study looking at effects of early PoPH on mortality in patients with cirrhosis #liversky @jhepatology.bsky.social www.journal-of-hepatology.eu/article/S016...
000
Atoosa Rabiee @atoosarabiee.bsky.social · 29/09/2025
Great review of reproductive health in the liver transplant recipient by Dr Sarkar et al journals.lww.com/lt/abstract/... #liversky
041
Atoosa Rabiee @atoosarabiee.bsky.social · 29/09/2025
Multinational real-world data supports lenvatinib as preferred second-line option in HCC treatment 👇🏼👇🏼👇🏼 www.jhep-reports.eu/article/S258... #liversky @easlnews.bsky.social
020
Atoosa Rabiee @atoosarabiee.bsky.social · 26/09/2025
If you are interested in portal hypertension and like to hear from all disciplines involved, this is the conference for you 👇🏼 Thank you for the invitation and the opportunity to review HRS-AKI and ascites management. #liversky @portal360mtg.bsky.social @bavenocoop.bsky.social
053
Atoosa Rabiee @atoosarabiee.bsky.social · 16/09/2025
In this study on reactivation of hepatitis B in patients with HCC ✅ Overall risk of HBV reactivation is low ✅ Risk is no affected by the choice of TKI or different types of ICI #Liversky onlinelibrary.wiley.com/doi/full/10....
040
Atoosa Rabiee @atoosarabiee.bsky.social · 16/09/2025
AlcHepNet consortium puts the focus on early intervention 712 AH patients Composite event 64% Liver transplant 12% Mortality in severe AH 17% (30d), 26% (90d), 30% (180d) Higher mortality: High MELD score Low MAP Leukocytosis #liversky @aasldnews.bsky.social journals.lww.com/hep/abstract...
030
Atoosa Rabiee @atoosarabiee.bsky.social · 10/09/2025
Save and keep it handy for when you are asked to “clear” patients with cirrhosis. Or as I prefer to say it “have a risk, benefit discussion before surgical procedures” There is also a visual highlight 🤩 journals.lww.com/ajg/fulltext... @amcollegegastro.bsky.social #liversky
052
Atoosa Rabiee @atoosarabiee.bsky.social · 08/09/2025
Updated Liver Transplant Guidelines from @aasldnews.bsky.social journals.lww.com/lt/abstract/... @livertransplant.bsky.social #Liversky
031
Atoosa Rabiee @atoosarabiee.bsky.social · 08/09/2025
A very comprehensive review on current state of HCC screening, diagnosis and treatment. www.jhep-reports.eu/article/S258... #Liversky @easlnews.bsky.social
043
Atoosa Rabiee @atoosarabiee.bsky.social · 22/08/2025
handy easy to read paper on Guidance for Timely Referral to Liver Transplantation www.cghjournal.org/action/showP... #liversky @ast-licop.bsky.social
051
Atoosa Rabiee @atoosarabiee.bsky.social · 22/08/2025
HE post TIPS - elective vs preemptive - different prevalence - different risk factors - different outcomes #liversky www.jhep-reports.eu/article/S258... @easlnews.bsky.social
020
Atoosa Rabiee @atoosarabiee.bsky.social · 22/08/2025
One approach to individualize approach to volume rescuscitation is to use POC US See this wonderful study addressing this 👇 www.jhep-reports.eu/article/S258... #liversky @easlnews.bsky.social
010
Atoosa Rabiee @atoosarabiee.bsky.social · 22/08/2025
A refresher on less common hepatitis: HDV AGA Clinical Practice Update on Management of Hepatitis Delta More and more advocate for universal testing in those with hepatitis B. #liversky www.gastrojournal.org/action/showP... @amergastroassn.bsky.social
001
Atoosa Rabiee @atoosarabiee.bsky.social · 22/08/2025
24 hour vs 48 hour for initial volume expansion and diagnosis of AKI-HRS? The debate continues... We can all agree that it should be individualized. #liversky www.journal-of-hepatology.eu/article/S016... www.journal-of-hepatology.eu/article/S016... @jhepatology.bsky.social
journal-of-hepatology.eu
From Protocol to Precision: The Evolving Diagnosis of Hepatorenal Syndrome
Angeli et al. endorse a historically adopted framework for management of acute kidney injury (AKI) that requires 48-hour albumin infusion to diagnosis HRS-AKI, an approach inconsistent with current un...
000
Reposted by Atoosa Rabiee
EASL @easlnews.bsky.social · 21/08/2025
In today’s #readoftheweek📚, the authors explore how TIPS could limit the risk of portal hypertensive complications in patients with ascites. Read here this JHEP Reports article: www.jhep-reports.eu/article/S258... #LiverSky
032
Atoosa Rabiee @atoosarabiee.bsky.social · 08/07/2025
In this interesting study They evaluated the hazards of ⬆️ distance from LT center on waitlist mortality and receipt of LT 📍No impact on LT waitlist mortality or receipt of LT. 📍Only differences in healthcare utilization in pre-LT #liversky journals.lww.com/ajg/abstract...
031
Atoosa Rabiee @atoosarabiee.bsky.social · 08/07/2025
A new but tested and tried mentorship method 👇🏼 Near-Peer mentorship 😊 @drjessicadavis.bsky.social Thank you for spearheading the project #liversky journals.lww.com/lt/abstract/...
021
Atoosa Rabiee @atoosarabiee.bsky.social · 24/06/2025
Thanks to our team at the VA and Georgetown, thanks to @drjessicadavis.bsky.social for spearheading the publication and most importantly thanks to our patients trusting us with their care. Very proud 😊
031
Atoosa Rabiee @atoosarabiee.bsky.social · 10/06/2025
2 🐥🐥 1 🪨 In this VA study, GLP-1 RA use was a/w a 📉 risk of liver outcomes, death, & harmful alcohol use #Liversky journals.lww.com/ajg/abstract... @amcollegegastro.bsky.social
142
Atoosa Rabiee @atoosarabiee.bsky.social · 06/06/2025
Congrats! What an accomplishment! So proud of you 😊
010
Reposted by Atoosa Rabiee
Thomas Reiberger @reibergerthomas.bsky.social · 01/06/2025
🚨 #LiverSky interested in #Cirrhosis and #PortalHypertension ➡️ Read the #Baveno VII Consensus 🔗 t.ly/1P7Ta Get Ready and Register for the #Baveno VIII Consensus 📆 27-28 MARCH 2026 🔗 baveno8.org @bavenocoop.bsky.social @easlnews.bsky.social @aasldnews.bsky.social
162
Reposted by Atoosa Rabiee
Rob Brierley @robbrierley.bsky.social · 21/05/2025
Among patients with previously untreated advanced HCC, the anti-PD-1 antibody toripalimab plus bevacizumab resulted in significantly longer PFS & OS than did sorafenib, with acceptable safety. The regimen has been approved for use in China. #oncsky #liversky #medsky @oncoalert.bsky.social
052